[1] |
. Cochrane Database Syst Rev, 2016(5): CD009491.
|
[2] |
Chen XJ, Mou XQ, He ZY, et al. The effect of midazolam on pain control after knee arthroscopy: a systematic review and meta-analysis[J]. J Orthop Surg Res, 2017, 12(1): 179.
|
[3] |
Grant MC, Kim J, Page AJ, et al. The effect of intravenous midazolam on postoperative nausea and vomiting: a meta-analysis[J]. Anesth Analg, 2016, 122(3): 656-663.
|
[4] |
Reddy SD, Reddy DS. Midazolam as an anticonvulsant antidote for organophosphate intoxication: a pharmacotherapeutic appraisal[J]. Epilepsia, 2015, 56(6): 813-821.
|
[5] |
Shtull-Leber E, Silbergleit R, Meurer WJ. Pre-hospital midazolam for benzodiazepine-treated seizures before and after the rapid anticonvulsant medication prior to arrival trial: a national observational cohort study[J]. PLoS One, 2017, 12(3): e0173539. doi:10.1371/journal.pone.0173539.
|
[6] |
Dao K, Giannoni E, Diezi M, et al. Midazolam as a first-line treatment for neonatal seizures: retrospective study[J]. Pediatr Int, 2018, 60(5): 498-500.
|
[7] |
Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit[J]. Cochrane Database Syst Rev, 2017, 1(1): CD002052.
|
[8] |
Sivaramakrishnan G, Sridharan K. Nitrous oxide and midazolam sedation: a systematic review and meta-analysis[J]. Anesth Prog, 2017, 64(2): 59-65.
|
[9] |
Santotoribio JD, Parodi Fernández V, Mesa Suárez P. Sedation with midazolam without neurotoxic effects[J].Med Clin (Barc), 2018,150(11):450.
|
[10] |
Cheng X, Chen L, Huang LN, et al. Determination of related substances of midazolam syrup by RP-HPLC[J]. Fujian Anal Test(福建分析测试), 2010, 19(2): 76-79.
|
[11] |
Huang CY, Chen MH, Cai M, et al. Preliminary exploration and structure identification of related substances of midazolam injection by 2D-LC-IT-TOF/MS[J]. Chin J Pharm Anal(药物分析杂志), 2017, 37(4): 688-694.
|
[12] |
Feng XL, Du G, Hou TY, et al. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MSn and NMR[J]. Pharmazie, 2017, 72(2): 73-80.
|
[13] |
Sati B, Sati H, Saklani S, et al. Synthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC[J]. Acta Pharm, 2013, 63(3): 385-396.
|
[14] |
The United States Pharmacopeia Convention. United States Pharmacopeia 43[S]. Rockville:The United States Pharmacopeia Convention, 2020: 2952-2953.
|
[15] |
Guo JF, Shan XY, Shi HL.Graphical synthetic routes of midazolam[J]. Chin J Pharm (中国医药工业杂志), 2012,43(5):82-84.
|
[16] |
Fu YG, Li L, Li J, et al. Study on conjugated system of midazolam[J]. Chem Bioeng (化学与生物工程), 2010, 27(10): 31-32, 36.
|
[17] |
Hou XY. Study on the stability of midazolam syrup solution(咪达唑仑糖浆混合液稳定性研究)[D]. Bejing:Peking Union Medical College, 2017.
|
[18] |
Yin XY, Wang C, Ming GJ, et al. Identification of the related substances in pioglitazone hydrochloride by hyphenated LC-MS techniques[J]. J China Pharm Univ(中国药科大学学报), 2017, 48(6): 701-710.
|
[19] |
Ni YL, Han X, Song M, et al. Identification of the related substances of cyclosporin A by LC-MS techniques[J]. J China Pharm Univ(中国药科大学学报), 2019, 50(4): 423-437.
|